Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04046718
NCT04046718CompletedNot Applicable

Lipid Profile Response to Electroacupuncture

Ramy Salama Draz1 site in 1 country60 target enrollmentStarted: August 22, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl)
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

sixty female patients suffering from non-alcoholic fatty liver disease were randomly divided into two equal groups group 1 received electroacupuncture stimulation for 6 weeks at special points of stimulation. group 2 was a control group that received nothing without any change in lifestyle and we assed the response of lipid profile post-treatment protocol in both groupes

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
30 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •non alcoholic fatty liver BMI 30-40

Exclusion Criteria

  • •Patients with: (Hepatitis C & b any form of seizure

Outcomes

Primary Outcomes

tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl)

Time Frame: 6 weeks

lowering of total lipid profile in study group

Secondary Outcomes

  • weight (kg) , height (m), BMI (kg/m2)(1st week)

Investigators

Sponsor
Ramy Salama Draz
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ramy Salama Draz

Principal Investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Electrical Impedance Tomography in Fatty Liver DetectionNon-Alcoholic Fatty Liver Disease
NCT05189990The University of Hong Kong160
Not yet recruiting
Unknown
se of hsCRP as a marker of severity in patients with non alcoholic fatty liver disease
CTRI/2024/05/066754Sanju George
Unknown
Not Applicable
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisNon-alcoholic Fatty Liver Disease
NCT03842748Beijing Municipal Administration of Hospitals300
Unknown
Not Applicable
Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.NASH - Nonalcoholic Steatohepatitis
NCT04653311Erasme University Hospital100
Unknown
Not Applicable
Hepaxa Management of Non-alcoholic Fatty Liver DiseaseNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
NCT03801577BASF AS50